1. Tardieu S, Brun-Strang C, Berthaud P et al (2005) Management of chronic myeloid leukemia in France: a multicentered cross-sectional study on 538 patients. Pharmacoepidemiol Drug Saf 14:545–553
2. Mottalib MA, Sultana TA, Khalil MI et al (2014) Phase distribution of chronic myeloid leukemia in Bangladesh. BMC Res Notes 7:142
3. Ahmed R, Naqi N, Hussain I et al (2009) Presentating phases of chronic myeloid leukaemia. J Coll Phys Surg Pak 19:469–472
4. Lindoerfer D, Hoffmann VS, Rosti G et al (2014) The EUTOS population-based registry: evaluation of baseline characteristics and first treatment choices of 3045 newly diagnosed chronic myeloid leukemia (CML) patients from 20 European countries. Haematologica. epub ahead of print: Abstract
5. Hochhaus A, Kim D-W, Shah NP et al (2013) Four-Year (Yr) Follow-Up Of Patients (Pts) With Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP) Receiving Dasatinib Or Imatinib: Efficacy Based On Early Response. Blood. 122: Abstract 653